Acacia Research Ramps Up Monetization and 4 Must-See Stock Analyses

Winnebago Industries Inc. (NYSE:WGO): Current Price: $18.59

Baird continues to think that the fundamentals of the RV sector remain solid and sentiment sees ongoing improvement, but when considering recent stock price increases in both Winnebago and Thor Industries (NYSE:THO), Baird continues to believe that investors begin to trim positions. Both Winnebago and Thor shares keep an Outperform rating.

Capture

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Get our fresh Feature Stock Pick now!

Viacom, Inc. (NASDAQ:VIAB): Current Price: $58.00

Stifel Nicolaus  predicts that improving ad trends along with international growth will cause Viacom’s EPS growth to accelerate, and it will allow the company to aggressively repurchase shares. The firm keeps its Buy rating on the stock.

Capture

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

WellCare Health Plans, Inc. (NYSE:WCG): Current Price: $46.05

Stifel continues to think that WellCare could potentially report poor Q4 results and may provide weak 2013 guidance, but the firm is convinced that short covering and purchases by longer term investors is likely to boost the stock, and it keeps its Buy rating and a $70 price target on the stock.

Capture

Matrix Service Co. (NASDAQ:MTRX): Current Price: $12.78

The company’s target has been raised by DA Davidson due to the firm’s belief that the market for refinery and petrochemical maintenance services were strong in the December period when considering reports from service providers. The firm keeps its Buy rating on the stock.

Capture

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Get our fresh Feature Stock Pick now!

Acacia Research Corporation (NASDAQ:ACTG): Current Price: $25.62

Cowen is convinced that the quality of asset patents that were acquired by Acacia Research continue to be under-appreciated, and predicts that they will be future revenue generators. The firm predicts growth acceleration as monetization efforts around recent acquisitions ramp. Shares have an Outperform rating.

Capture

Don’t Miss: Celgene Upgraded to Outperform and 2 Healthcare Stocks on the Move.